Fagron US

Humco by Fagron and FagronLab™ will be at Cencora ThoughtSpot 2026 in Orlando (July 28–Aug 1). Swing by the booth to get a first look at what's new across our equipment and portfolio: Equipment on display: Apo-Ident™ 2 and the FagronLab™ PM140. Portfolio highlights: the full Tricholine™ range, Phytobase, HRT Heavy, our flavor line, and a broad selection of base samples. Reserve your in-person equipment demo ahead of the show: https://lnkd.in/gX5d9R4H For licensed compounding professionals only. Items shown are bulk pharmaceutical ingredients and compounding vehicles — not FDA-approved finished drug products. #CencoraThoughtSpot2026 #Fagron #Humco #PersonalizedCompounding #Compounding #PharmacyInnovation #TradeShow #Orlando

MOTs-C is scheduled for discussion by the Pharmacy Compounding Advisory Committee (PCAC) in July 2026. As interest in peptides continues to grow among patients and prescribers, it is important for compounding pharmacists and healthcare professionals to stay informed on the ever-evolving regulatory landscape.  Our latest Fagron Academy blog provides a practical overview of MOTs-C, including: • Its role as a mitochondrial-derived peptide involved in energy metabolism, insulin sensitivity, inflammatory response, and aging • Its proposed cellular mechanisms and metabolic pathways • What the upcoming FDA PCAC discussion could mean for compounding pharmacies The FDA is scheduled to consult PCAC on July 23–24 regarding whether MOTs-C and several other peptides should be added to the 503A bulks list. Fagron Academy is here to help you to prepare for conversations with patients and prescribers. For professional use only. Intended for licensed compounding pharmacists and healthcare professionals. Read the full blog and help your pharmacy stay ahead of the conversation.  https://lnkd.in/g4AhX_SC #CompoundingPharmacy #Peptides #MOTsC #PharmacyEducation #FDA #PCAC #PersonalizedMedicine #FagronAcademy

Over the past couple of weeks, we've shared key technical resources designed to support licensed compounding pharmacists in optimizing formulation workflows and compounding infrastructure: July 14: HRT Heavy™ BUD Data Deep Dive – We unveiled our validated Beyond-Use Date (BUD) data for 17 high and low concentration single and combination hormone replacement formulations. Backed by exhaustive stability and USP <795>/<51> AET testing, these findings provide up to 180-day max BUDs, supporting batch efficiency, waste reduction, and API chemical stability consistent with USP-defined assay compliance. July 21: TrichoSol™ Formulation Field Guide – Building on our recent technical insights, we released our comprehensive Formulation Field Guide featuring 85 TrichoSol™ reference formulations ranging from single-API solutions to complex four-active combinations (including Minoxidil, Finasteride, Dutasteride, and Spironolactone). This guide highlights clean, hydrophilic vehicle compatibility engineered to exclude aggressive solvents while supporting formulation precision for trichology compounding. Both resources are engineered to provide your team with the rigorous scientific data and infrastructure needed to advance the science of personalized compounding. Check your inbox for the full studies and download links, or reach out to caroline.dollar@fagron.us to learn more! For use by licensed compounding professionals only. Not intended for direct patient use. This material is a bulk pharmaceutical ingredient/vehicle and is not an FDA-approved finished drug product. Not for retail sale. Compounded preparations utilizing this material require a valid patient-specific prescription and must be prepared by a licensed pharmacist in compliance with applicable federal and state laws, including Sections 503A/503B of the Federal Food, Drug, and Cosmetic Act. Visit the site to purchase the APIs & compounding vehicles here: https://lnkd.in/guqs-t4y To learn more about compounding medicine visit: https://lnkd.in/gCWN8fut #CompoundingPharmacy #TrichologyCompounding #FormulationScience #StabilityTesting #USP795 #Fagron

The countdown is on! Humco by Fagron and FagronLab™ are heading to Cardinal Health RBC 2026 (July 22–24), and we can't wait to show you what's next in compounding. Come see it for yourself: - Equipment on display: FagronLab™ PM140 and the Pete Pharma / FABRx M3DIMAKER™ 3D Printer - Full product lineup: Fagron & HUMCO offerings including Tricholine™, Phytobase, HRT Heavy, our flavor line, and more Find us at the Orange County Convention Center — we'd love to connect in person! Want a personalized demo? Book yours here: https://lnkd.in/gX5d9R4H #CardinalHealthRBC #RBC2026 #Fagron #Humco #CompoundingPharmacy #PersonalizingMedicine #TradeShow #Orlando2026

BPC-157, KPV, TB-500, and MOTs-C to be Discussed at July PCAC Meeting As questions around peptides continue to grow, it is important for compounding pharmacists and healthcare professionals to stay informed about the evolving regulatory landscape.  The FDA is scheduled to consult PCAC on July 23–24 regarding whether BPC-157 and several other peptides should be added to the 503A bulks list. This is a timely opportunity to prepare for patient and prescriber questions.  Read the full blog and help your pharmacy stay ahead of the conversation.  #CompoundingPharmacy #Peptides #BPC157 #PharmacyEducation #FDA #PCAC #PersonalizedMedicine #FagronAcademy  For professional use only. Intended for licensed compounding pharmacists and healthcare professionals. Read the full blog and help your pharmacy stay ahead of the conversation. https://lnkd.in/g3MSZjvc

Ready to expand your trichology compounding formulary? Our TrichoLine™ offers vehicle systems built to pair with Minoxidil, Finasteride, Dutasteride, and other trichology-relevant APIs. Highlights from our BUD validation program: - 180-day BUDs supported for select TrichoFoam™ & TrichoSol™ formulations - 31 preparations tested for stability and Antimicrobial Effectiveness (USP <51>), in alignment with updated USP <795> requirements - Excipient profiles free of parabens, propylene glycol, mineral oil/petrolatum, and more For use by licensed compounding professionals only. This material is a bulk pharmaceutical ingredient/vehicle and is not an FDA-approved finished drug product. Not for retail sale. Compounded preparations utilizing this material require a valid patient-specific prescription and must be prepared by a licensed pharmacist in compliance with applicable federal and state laws, including Sections 503A/503B of the Federal Food, Drug, and Cosmetic Act. Visit Fagron Academy to learn more: https://lnkd.in/gCWN8fut To purchase APIs or bases from Fagron, visit: https://lnkd.in/guqs-t4y #CompoundingPharmacy #FagronAcademy #TrichoCompounding #USP795 #CompoundingScience

Humco by Fagron and FagronLab™ are headed to Cencora ThoughtSpot 2026 (July 28–Aug 1). Stop by to learn more about our latest innovations: Equipment: Apo-Ident™ 2, Pete Pharma / FABRx M3DIMAKER™ 3D Printer, and FagronLab™ PM140. Portfolio: Full Tricholine™, Phytobase, HRT Heavy, flavor line, and a wide array of base samples. Schedule your in-person equipment demo here: https://lnkd.in/gX5d9R4H #CencoraThoughtSpot2026 #Fagron #Humco #PersonalizingMedicine #Compounding #PharmacyInnovation #TradeShow #Orlando

Humco by Fagron and FagronLab™ are counting down the days until Cardinal Health RBC 2026 (July 22–24). Join us for an exclusive look at the future of compounding. See it in action: Equipment: FagronLab™ PM140 & Pete Pharma / FABRx M3DIMAKER™ 3D Printer. Portfolio: Explore our full range of Fagron & HUMCO products, including the Tricholine™, Phytobase, HRT Heavy, flavor line, and more! Stop by our booth at the Orange County Convention Center! To book a personalized demo visit: https://lnkd.in/gX5d9R4H #CardinalHealthRBC #RBC2026 #Fagron #Humco #CompoundingPharmacy #PersonalizingMedicine #TradeShow #Orlando2026

Fagron's compounding partners received a technical overview this week — here's a look at what was included. The mailing covered HRT Heavy™ and Phytobase® — each characterized for API compatibility across a broad range of HRT formulations. Highlights included up to 180-day BUDs on 280+ preparations and reference formulations from a combined 515+ formula library. Licensed compounding professionals looking to build or refine an HRT or Phytobase compounding formulary can reach out to meghan.stevenson@fagron.us to request the full formularies and complete BUD study documentations. For use by licensed compounding professionals only. This material is a bulk pharmaceutical ingredient/vehicle and is not an FDA-approved finished drug product. Not for retail sale. Compounded preparations utilizing this material require a valid patient-specific prescription and must be prepared by a licensed pharmacist in compliance with applicable federal and state laws, including Sections 503A/503B of the Federal Food, Drug, and Cosmetic Act. Visit Fagron Academy to learn more: https://lnkd.in/gCWN8fut  To purchase APIs or bases from Fagron, visit: https://lnkd.in/guqs-t4y #CompoundingPharmacy #FagronAcademy #HRTCompounding #USP795 #CompoundingScience

Humco by Fagron and FagronLab™ will be exhibiting at Cencora ThoughtSpot 2026 — July 28 through August 1 in Orlando, FL. Stop by our booth and connect with our team! You'll find Nicholas Fournarakis, Steve Anderson, and Andrew Ramirez on the floor, ready to talk compounding solutions, product innovations, and everything Humco and FagronLab™ have to offer. See our latest technology in action — including the Pete Pharma / FABRx M3DIMAKER™ 3D Printer, Apo-Ident™ 2, and the FagronLab™ PM140 — and discover how these tools can elevate your pharmacy's compounding workflow. Visit us to discuss how we are personalizing medicine together. Attending ThoughtSpot? Drop a comment — we'd love to schedule time to connect. Visit https://lnkd.in/gX5d9R4H to schedule a FagronLab™ equipment demonstration! #CencoraThoughtSpot2026 #Fagron #Humco #PersonalizingMedicine #Compounding #PharmacyInnovation #TradeShow #Orlando